• Home
  • Search Results

Search Results

Adult (35-64)
2201 studies match your search
Not currently enrolling

Skin Health Awareness and Preventative Practices

The purpose of this study is to understand how much people know about skin cancer and how they protect their skin. We are looking at people's knowledge about different types of skin cancer and their behaviors to prevent it. We want to see if there are common habits or barriers that affect how people take care of their skin. By learning more about these things, we hope to improve ways to promote skin health and prevent skin cancer.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Skin, Hair, and Nails
Visit Location
100% Remote (online, phone, text)
Open

4-Week Smart Ring Technology Trial

Do you want to try out a smart ring? Do you want to get access to smartphone application which provides insightful information about your overall health, sleep, and activity? If you are between 40-59 years old, you may be able to participate in a research study assessing the feasibility and acceptability of Oura Rings.

Age & Gender
  • 40 years ~ 59 years
  • Male, Female, Gender Inclusive
Study Interest
  • Healthy Volunteer or General Population
Open

Well-being and Heart Health Study

Do you struggle with ways to feel more relaxed or calm when you are stressed? Do you identify as African American, Black, Hispanic, and/or Latino (a/e/x)? If so, you may be able to take part in a study to see whether a home-based training program can improve emotional well-being and heart health. Compensation provided.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Alternative or Complementary Medicine
  • Mental and Emotional Health
  • Wellness and Lifestyle
  • and 3 more
Visit Location
100% Remote (online, phone, text)
Open

Advanced Melanoma Treatment Study

Do you have advanced melanoma that has progressed on treatment? Do you have a tumor longer than 1cm in length? If so, you might be able to take part in a study that compares a study treatment (Vusolimogene Oderparepvec and Nivolumab) with your physician's choice of standard of care treatment. Compensation provided.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Melanoma)
Open

PUMA-ALI-1201: A PHASE 2 STUDY OF ALISERTIB IN COMBINATION WITH ENDOCRINE THERAPY IN PATIENTS WITH HR+, HER2-NEGATIVE RECURRENT OR METASTATIC BREAST CANCER

Have you been diagnosed with hormone receptor (HR+) and human epidermal growth factor receptor 2 (HER2)-negative recurrent or metastatic breast cancer? If so, you may be eligible for a clinical trial investigating the combination of endocrine therapy with alisertib.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Breast)
Open

Rehabilitation outcomes study

Have you been diagnosed with cancer. If so, you may be able to take part in a research study looking to improve cancer care for patients whose treatment outcomes have led to challenges in their quality of life.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Bladder, Brain and Other Nervous System, Breast, and 19 more)
Open

Parkinson's Disease Treatment study

Do you have moderate Parkinson's disease with motor symptoms? Are you over 45 years old? You may be able to participate in a research study to find out if a new treatment involving surgery can help with your symptoms. Compensation provided.

Age & Gender
  • 45 years ~ 75 years
  • Male, Female, Gender Inclusive
Study Interest
  • Brain, Head, Nervous System
Visit Location
Not currently enrolling

Hypertonic Saline in Non-CF Bronchiectasis

The purpose of this research study is to evaluate the effects of 7% hypertonic saline (HS) delivered by nebulizer on mucociliary clearance (MCC) - a test that shows the rate at which a person's lungs can clear inhaled particles. We will compare the rate of MCC at baseline (before treatment with HS), with MCC after a single dose of HS (acute treatment), and with MCC after two weeks of treatment with HS twice a day after 12 hours from the last dose of HS (sustained effect). We will also assess response to HS with other outcomes (lung function testing, changes in phlegm/mucus, and survey responses). If we find there is a sustained effect of HS, this would support the use of HS as part of airway clearance for people with bronchiectasis.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Chronic Conditions
  • Lungs and Breathing
Open

Basal-like PDAC treated with Gemcitabine, Erlotinib and nab-paclitaxel (PANGEA).

Are you a patient with advanced basal-like pancreatic adenocarcinoma? If so this could the a Trial for you to as this is a Phase I/II trial is to evaluate the safety, efficacy and tolerability of low-dose EGFR inhibitors in combination with bi-weekly gemcitabine/nab-paclitaxel (GnP) in subjects with basal tumors

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Pancreatic)
Open

Suicidality in Adolescents Following Psychiatric Hospitalization

Is your child being hospitalized at UNC Youth Behavioral Health for suicidal thoughts or behaviors? If so, you may be eligible to participate in a research study to identify the risk factors associated with recurrence of suicidal thoughts after psychiatric hospitalization. Both you and your child must participate to be eligible for the research study. Compensation provided.

Age & Gender
  • 12 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Child and Teen Health
  • Mental and Emotional Health
  • Parents of Children
  • and 2 more
Visit Location
100% Remote (online, phone, text)
Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research